Labeguere; Frederic Gilbert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Labeguere; Frederic Gilbert.The latest application filed is for "novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders.".

Company Profile

0.8.1

Labeguere; Frederic Gilbert - Gagny FR
Labeguere; Frederic Gilbert - Frouzins FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders Grant 11,220,499 - Labeguere , et al. January 11, 2	2022-01-11
5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritis Grant 10,829,478 - Labeguere , et al. November 10, 2	2020-11-10
5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritis Grant 10,550,100 - Labeguere , et al. Fe	2020-02-04
6-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-B]pyridin-3-yl]-nicotinonitrile derivatives and their use as IRAK inhibitors Grant 10,508,111 - Brys , et al. Dec	2019-12-17
Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders Grant 10,047,083 - Labeguere , et al. August 14, 2	2018-08-14
Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders (GPR84 antagonists) Grant 9,708,312 - Labeguere , et al. July 18, 2	2017-07-18
Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders Grant 9,255,095 - Labeguere , et al. February 9, 2	2016-02-09
Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders Grant 8,927,543 - Labeguere , et al. January 6, 2	2015-01-06
Novel Dihydropyrimidinoisoquinolinones And Pharmaceutical Compositions Thereof For The Treatment Of Inflammatory Disorders. App 20140121204 - Labeguere; Frederic Gilbert ; et al.	2014-05-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.